CDKN1A and cancer: Several studies have linked the overexpression of cytoplasmic p21 to decreased responsiveness to chemotherapy and radiotherapy (Liu et al., 2003) and poor prognosis in numerous cancers (Baretton et al., 1999; Bae et al., 2001; Cheung et al., 2001).